Phase 3 Study of Avacopan for the Treatment of ANCA-Associated Vasculitis: ADVOCATE

Study Findings: Patients who received avacopan were more likely to stay in remission versus those who were only taking prednisone. View Publication.

ClinicalTrials.gov ID: NCT02994927

Study Dates: 2017-2020

Disease(s): Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis (MPA)